Introduction:

In the context of the COVID-19 pandemic, the increase of information on children severely affected by a new form of disease similar to Kawasaki syndrome set off alarms worldwide.

Objective:

Analyze the available evidence and describe the presentation, symptoms and treatments of the disease called new Kawasaki associated with COVID-19 in the pediatric population.

Methods:

A systematic review of studies published in scientific search engines like PubMed, Cochrane, ScienceDirect, Medline was carried out, between December 2019 and September 2020, which included the pediatric population between 0-18 years.

Analysis and integration of information:

After the application of the inclusion and exclusion criteria, 15 articles remained for analysis, with a total sample of 932 patients, who presented the disease associated with COVID-19. A high percentage of signs of severity such as cardiac complications are found. In the studies that recorded these signs, the prevalence varies between 60-100% of patients and between 50-100% in the shock associated with increased inflammatory parameters. In general terms, the prognosis was favorable in most of the patients. There were only 9 deaths (0.97%) of the total sample.

Conclusions:

Timely treatment is associated with a good prognosis in these patients, with a low mortality rate. Therefore, it is essential that both the medical community and the general population are properly informed about this condition and its clinical presentation.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )